RXSTRxSight, Inc.

$303M

Q3 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$6M+38.8% YoY

Gross Profit

$1M23.2% margin

Operating Income

-$13M-226.6% margin

Net Income

-$13M-219.0% margin

EPS (Diluted)

$-0.68

QoQ Revenue Growth

+18.2%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$14M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$204M

Total Liabilities

$53M

Stockholders' Equity

$151M

Cash & Equivalents

$68M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$4M	+38.8%
Gross Profit	$1M	$720,000	+86.3%
Operating Income	-$13M	-$9M	-47.2%
Net Income	-$13M	$31M	-141.3%

Revenue Segments

L D D

$4M63%

RxLAL

$2M34%

Service Warranty Service Contracts And Accessories

$181,0003%

RXST Q3 2021 Earnings — RxSight, Inc. Revenue & Financial Results | Market Cap Arena